Wednesday, June 22, 2011

New Cystic fibrosis drug development

An international team of scientists has developed a new drug for cystic fibrosis sufferers.
VX-770 targets people with the 'celtic gene', a genetic mutation particularly common in patients with the condition.
VX-770 works by opening the defective channel in lungs cells of people with cystic fibrosis. It is the first treatment aimed at this basic defect to show an effect.


Post a Comment

Note: Only a member of this blog may post a comment.

Related Posts Plugin for WordPress, Blogger...

Design by Wordpress Theme | Bloggerized by Free Blogger Templates | coupon codes
Visit InfoServe for Blogger backgrounds.